FAM98B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.821000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.827800E-01
Normal-vs-Stage2
6.887800E-01
Normal-vs-Stage3
2.437800E-01
Normal-vs-Stage4
9.906000E-01
Stage1-vs-Stage2
8.036800E-01
Stage1-vs-Stage3
2.103800E-01
Stage1-vs-Stage4
7.419200E-01
Stage2-vs-Stage3
3.824800E-01
Stage2-vs-Stage4
6.513600E-01
Stage3-vs-Stage4
1.443420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.779400E-01
Normal-vs-AfricanAmerican
8.087600E-01
Normal-vs-Asian
3.063400E-01
Caucasian-vs-AfricanAmerican
3.336000E-01
Caucasian-vs-Asian
1.163450E-01
AfricanAmerican-vs-Asian
1.161220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.340400E-01
Normal-vs-Female
7.641800E-01
Male-vs-Female
4.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.458400E-01
Normal-vs-Age(41-60Yrs)
9.233600E-01
Normal-vs-Age(61-80Yrs)
6.338000E-01
Normal-vs-Age(81-100Yrs)
2.772800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.352600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.158400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.234800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.452200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.131000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.279600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.055800E-01
Normal-vs-Daily Drinker
5.076200E-01
Normal-vs-Weekly Drinker
4.491200E-01
Normal-vs-Occasional Drinker
9.544200E-01
Normal-vs-Social Drinker
8.388600E-01
Non Drinker-vs-Daily Drinker
7.349600E-01
Non Drinker-vs-Weekly Drinker
8.328200E-01
Non Drinker-vs-Occasional Drinker
1.757800E-01
Non Drinker-vs-Social Drinker
3.369200E-01
Daily Drinker-vs-Weekly Drinker
9.080400E-01
Daily Drinker-vs-Occasional Drinker
2.101600E-01
Daily Drinker-vs-Social Drinker
3.457600E-01
Weekly Drinker-vs-Occasional Drinker
2.418600E-01
Weekly Drinker-vs-Social Drinker
3.815400E-01
Occasional Drinker-vs-Social Drinker
7.943200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.794600E-01
Normal-vs-Grade 2
1.468810E-01
Normal-vs-Grade 3
9.998400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.150800E-01
Grade 1-vs-Grade 3
2.338800E-01
Grade 1-vs-Grade 4
2.794600E-01
Grade 2-vs-Grade 3
2.116400E-01
Grade 2-vs-Grade 4
1.468810E-01
Grade 3-vs-Grade 4
9.998400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.041800E-01
Normal-vs-NonDiabetic
6.005800E-01
Diabetic-vs-NonDiabetic
6.063800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.899180E-01
Normal-vs-NoPancreatitis
6.730200E-01
Pancreatitis-vs-NoPancreatitis
2.813600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.222800E-01
Normal-vs-N1
7.359600E-01
N0-vs-N1
6.653800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.945200E-01
Normal-vs-TP53-NonMutant
8.800800E-01
TP53-Mutant-vs-TP53-NonMutant
6.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
